ArticleScience translational medicine2023

Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies.

Wei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.